Frankfurt
03.04.25
08:01 Uhr
0,029 Euro
0,000
0,00 %
0,00 %
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | |
|---|---|---|---|---|
| 05.03. | IMMURON LIMITED: Immuron CEO presentation to Coffee Microcaps Conference | - | ASX | |
| 05.03. | Immuron Limited: Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS) | 5 | GlobeNewswire (USA) | |
| IMMURON Aktie jetzt für 0€ handeln | ||||
| 04.03. | IMMURON LIMITED: IMC and Calmino to treat Irritable Bowel Syndrome (IBS) | - | ASX | |
| 28.02. | Immuron Ltd - 6-K, Report of foreign issuer | - | SEC Filings | |
| 28.02. | IMMURON LIMITED: Appendix 4D and Half Year Report | - | ASX | |
| 19.02. | Immuron Ltd - 6-K, Report of foreign issuer | - | SEC Filings | |
| 17.02. | IMMURON LIMITED: Immuron CEO presentation to Emerging Growth Conference | - | ASX | |
| 17.01. | IMMURON LIMITED: Notice under section 708A | 3 | ASX | |
| 17.01. | IMMURON LIMITED: Application for quotation of securities - IMC | 1 | ASX | |
| 17.01. | IMMURON LIMITED: Immuron Travelan continued strong sales growth | 4 | ASX | |
| 15.01. | Immuron Partners With Monash University To Combat Antimicrobial Resistance | 1 | RTTNews | |
| 15.01. | Immuron Ltd - 6-K, Report of foreign issuer | - | SEC Filings | |
| 15.01. | IMMURON LIMITED: Proposed issue of securities - IMC | 3 | ASX | |
| 14.01. | Immuron progresses development of traveller's diarrhea drug Travelan | 4 | The Market Herald Australia | |
| 14.01. | IMMURON LIMITED: Immuron Announces Travelan Clinical Trial Update | 3 | ASX | |
| 13.01. | IMMURON LIMITED: Immuron Announces Monash AMR Research Collaboration | 1 | ASX | |
| 08.01. | IMMURON LIMITED: Notice under section 708A | - | ASX | |
| 08.01. | IMMURON LIMITED: Application for quotation of securities - IMC | - | ASX | |
| 08.01. | Immuron Ltd - 6-K, Report of foreign issuer | - | SEC Filings | |
| 08.01. | IMMURON LIMITED: Proposed issue of securities - IMC | 2 | ASX |
Seite:
1 2 3 Weiter >>
52 Nachrichten in den letzten 12 Monaten
Das Unternehmen IMMURON LIMITED kann der Branche Biotechnologie zugeordnet werden. Der aktuelle Kurs liegt bei 0,029 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu IMMURON LIMITED finden Sie auf Wallstreet Online.
